Home › Icagen Issued U.S. Patent Covering Diagnostic And Discovery Applications Of Its Proprietary XRpro X-Ray Fluorescence Technology
 

Keywords :   


Icagen Issued U.S. Patent Covering Diagnostic And Discovery Applications Of Its Proprietary XRpro X-Ray Fluorescence Technology

2016-06-01 06:00:52| drugdiscoveryonline Home Page

Icagen, Inc. recently announced that the U.S. Patent and Trademark Office has granted the company patent number 9,335,284 B2, “Methods for Analysis Using X-Ray Fluorescence,” covering applications of the company’s proprietary XRpro X-ray fluorescence technology to the development of biomarkers and diagnostics

Tags: technology applications issued patent

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
14.05Cow dung's key role in India's energy industry
14.05May hay stocks provide early perspective on 2024 hay supply
13.05Dantex announces new digital director for Pico division
13.05Tonny De Beer Joins First Quality
13.05Join us for the 2024 Global Hog Industry Virtual Conference
13.05New version of Chat-GPT can teach maths and flirt
13.05Eastern North Pacific Tropical Weather Outlook
13.05Melinda French Gates to quit Gates Foundation
More »